Lv1
60 积分 2022-03-19 加入
Dual‐Specificity Tyrosine Phosphorylation–Regulated Kinase 3 Loss Activates Purine Metabolism and Promotes Hepatocellular Carcinoma Progression
1个月前
已完结
Cytosolic levels of TFF1/pS2 in breast cancer: their relationship with clinical–pathological parameters and their prognostic significance
4个月前
已完结
Are trefoil factors oncogenic?
4个月前
已完结
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
4个月前
已完结
Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer
5个月前
已完结
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy
5个月前
已完结
Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study
5个月前
已完结
Survival outcomes of neoadjuvant versus adjuvant therapy in patients with T1c, node‐negative, human epidermal growth factor receptor 2–positive breast cancer: A Surveillance, Epidemiology, and End Results population‐based study
11个月前
已完结
Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implications
1年前
已完结
Dissecting super-enhancer heterogeneity: time to re-examine cancer subtypes?
1年前
已完结
皖公网安备34019202002308
